5-Amino-1MQ is a small molecule inhibitor of Nicotinamide N-methyltransferase (NNMT), a key enzyme involved in cellular metabolism and energy regulation.
By targeting NNMT activity, 5-Amino-1MQ has been widely studied for its role in metabolic modulation, fat reduction, and energy expenditure pathways.
Originally explored for its impact on obesity and metabolic disorders, 5-Amino-1MQ has demonstrated potential in improving cellular energy balance, regulating adiposity, and supporting metabolic efficiency in preclinical research.
Researched Benefits:
- Enables investigation of NNMT inhibition and its downstream metabolic effects
- Supports analysis of cellular energy expenditure and mitochondrial activity
- Facilitates studies on fat mass reduction and adipose tissue regulation
- Useful in exploring NAD+ metabolism and methylation pathways
- Assists in modeling metabolic syndrome and obesity-related mechanisms
Description
5-Amino-1MQ (50mg) is a research-grade compound utilized in advanced metabolic and obesity-related studies. Manufactured with precision and high-purity standards, it is designed for consistent and reliable performance in laboratory settings.
Key Features:
- High-purity synthesis with strict quality control
- Batch-tested for consistency and research reliability
- Stable formulation suitable for extended storage
- Precisely dosed (50mg) for controlled experimental use
Applications:
- Investigates fat metabolism and energy regulation pathways
- Explores NNMT-related mechanisms in obesity research
- Supports studies on cellular energy balance and metabolic efficiency
- Examines potential roles in improving body composition in research models
5-Amino-1MQ is widely recognized in research for its ability to modulate metabolic pathways through NNMT inhibition, offering a unique approach to studying fat loss and energy regulation without directly impacting traditional hormonal systems.
